TrialScientific reports2019

Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052).

Ruoyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.